Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Oral Cyanocobalamin (Eligen B12) Bioavailability Study

This study has been completed.
Information provided by:
Emisphere Technologies, Inc. Identifier:
First received: March 8, 2011
Last updated: NA
Last verified: March 2011
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2008
  Estimated Primary Completion Date: No date given
No publications provided by Emisphere Technologies, Inc.

Publications automatically indexed to this study by Identifier (NCT Number):